Gemcitabine HCL Market 2019-2030 Analysis Examined in New Market Research Report with Focusing Key Players Like Accord Healthcare, Pfizer and Sun Pharmaceutical Etc
Gemcitabine HCL (hydrochloride) is an intravenous drug that is used to treat cancers like lung, breast, pancreatic, and ovarian, etc. This drug is injected directly into the vein by the physician. Gemcitabine hydrochloride is injected in the vein for at least 30 minutes. It significantly slows down or stops the growth of cancer cells in the body. The chemotherapy medication is normally given to the patient weekly for the running 3 weeks. Some treatments are prescribed to be given for...
View full press release